BioGaia AB (FRA:BGLA)
€ 9.115 -0.035 (-0.38%) Market Cap: 931.59 Mil Enterprise Value: 835.03 Mil PE Ratio: 31.83 PB Ratio: 6.64 GF Score: 95/100

Q2 2022 Biogaia AB Earnings Call Transcript

Jul 22, 2022 / 07:30AM GMT
Release Date Price: €10.7 (+0.94%)
Operator

Good morning, and welcome to the BioGaia Conference Call. (Operator Instructions) Please note this event is being recorded.

I'd now like to turn the conference over to Isabelle Ducellier, CEO. Thank you, and over to you, ma'am.

Isabelle Valerie Ghislaine Ducellier;publ;CEO;President
BioGaia AB

()-&

Thank you, and good morning, everybody. So following a very strong quarter -- first quarter, I'm actually very pleased to present yet another very strong quarter with sales up with 42%, mainly driven by strong growth in Europe and with plus 26% organic growth. I mean we are pretty proud to say that we outperformed the probiotics market during this quarter. In terms of EBIT, thanks to close cost monitoring, we can here as well present strong figures with an increase of 46%. And to end up this executive summary, it's worth mentioning a strong operating cash flow at SEK 87 million.

Next page, please. Looking at key events, I just would like to have your attention on the press release we found on 17th

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot